April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Angiographic Findings In Stargardt Disease: A Multimodalities Approach
Author Affiliations & Notes
  • Marco Pellegrini
    Eye Clinic, Department of Clinical Science, Sacco Hospital, University of Milan, Italy
  • Elisa Carini
    Eye Clinic, Department of Clinical Science, Sacco Hospital, University of Milan, Italy
  • Antonio Peroglio Deiro
    Eye Clinic, Department of Clinical Science, Sacco Hospital, University of Milan, Italy
  • Marta Oldani
    Eye Clinic, Department of Clinical Science, Sacco Hospital, University of Milan, Italy
  • Giovanni Staurenghi
    Eye Clinic, Department of Clinical Science, Sacco Hospital, University of Milan, Italy
  • Footnotes
    Commercial Relationships  Marco Pellegrini, None; Elisa Carini, None; Antonio Peroglio Deiro, None; Marta Oldani, None; Giovanni Staurenghi, Heidelberg Engineering (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5018. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Marco Pellegrini, Elisa Carini, Antonio Peroglio Deiro, Marta Oldani, Giovanni Staurenghi; Angiographic Findings In Stargardt Disease: A Multimodalities Approach. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5018.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Purpose of the study was to define and compare different imaging modalities in Stargardt Disease.

Methods: : 24 eyes from 12 consecutive patients affected by Stargardt Disease were evaluated using two different confocal scanning laser ophthalmoscopes (HRA2 and Spectralis HRA+OCT; Heidelberg Engineering, Heidelberg, Germany) in order to compare Fundus Autofluorescence (FAF), Fluorescein and Indocyanine Green angiography (FA and ICGA) findings; color fundus photography and SD-OCT were also performed to better characterize angiographic features.

Results: : Patient mean age was 50 years (range 17-78 years) and mean visual acuity 20/100 (range 20/800-20/25). At FA and Fundus Autofluorescence (FAF) examinations 16 eyes showed Overt Atrophic Macular Lesions (group 1) while 8 had Not Overt Macular Atrophy (group 2); group 2 eyes had the same visual acuity of group 1. Dark choroid was detected in 18 eyes (87% of group 1 and 50% of group 2). At FAF 62.5% of eyes belonging to group 1 showed an iperfluorescent ring around the central atrophic lesions while 100% presented an iperfluorescence of atrophy margins in FA. In Late-Phase ICGA (20-40 minutes since dye injection) atrophy appeared as an area of decreased fluorescence showing dark choroidal vessels and transparent margins. Group 2 eyes did not show any iperfluorescent boundary neither in FAF nor FA. In ICGA they appeared as an irregular area of decreased fluorescence with no evident vessels below. In 33.3% the size of macular lesions appeared wider in Late-Phase ICGA than in FAF/AF. Middle-Late phase ICGA revealed also the presence of tiny iperfluorescent dots in 100% of eyes: these showed the same location of retinal flecks, which appeared in ICGA to mask background fluorescence.

Conclusions: : Combined examination using different imaging techniques allowed a more complete evaluation of Stargardt Disease angiographic findings. The presence of characteristic features detectable in almost all patients suggests they could be pathognomonic for this condition; however the real meaning of these signs remains to be defined.

Keywords: retina • retinal degenerations: hereditary • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×